488 related articles for article (PubMed ID: 31412635)
41. Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients.
Assiri AMA; Kamel HFM; ALrefai AA
Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29789493
[TBL] [Abstract][Full Text] [Related]
42. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
[TBL] [Abstract][Full Text] [Related]
43. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
[TBL] [Abstract][Full Text] [Related]
44. First-Days Reduction of Plasma and Skin Advanced Glycation End Products is Related to Outcome in Septic Patients.
Rodriguez-Ruiz E; Lopez-Lago A; Hernandez-Vaquero R; Granja-Gomez I; Estany-Gestal A; Alvarez E; Garcia-Gonzalez M; Garcia-Allut JL
Shock; 2020 Apr; 53(4):400-406. PubMed ID: 31232862
[TBL] [Abstract][Full Text] [Related]
45. The role of sRAGE in cardiovascular diseases.
Delrue C; Delanghe JR; Speeckaert MM
Adv Clin Chem; 2023; 117():53-102. PubMed ID: 37973322
[TBL] [Abstract][Full Text] [Related]
46. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
47. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
48. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
[TBL] [Abstract][Full Text] [Related]
49. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor.
Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S
Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591
[TBL] [Abstract][Full Text] [Related]
50. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
Prasad K
Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
[TBL] [Abstract][Full Text] [Related]
51. Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
Diekmann F; Chouvarine P; Sallmon H; Meyer-Kobbe L; Kieslich M; Plouffe BD; Murthy SK; Lichtinghagen R; Legchenko E; Hansmann G
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445297
[TBL] [Abstract][Full Text] [Related]
52. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
53. Association of plasma advanced glycation end-products and their soluble receptor with type 2 diabetes among Chinese adults.
Chen L; Wang Q; Lv Y; Xu W; Jiang G; Li Y; Luo P; He R; Liu L
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3735. PubMed ID: 37817474
[TBL] [Abstract][Full Text] [Related]
54. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
[No Abstract] [Full Text] [Related]
55. The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts.
Mitran CI; Nicolae I; Tampa M; Mitran MI; Caruntu C; Sarbu MI; Ene CD; Matei C; Ionescu AC; Georgescu SR; Popa MI
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635193
[TBL] [Abstract][Full Text] [Related]
56. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
57. Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
Corica D; Aversa T; Ruggeri RM; Cristani M; Alibrandi A; Pepe G; De Luca F; Wasniewska M
Front Endocrinol (Lausanne); 2019; 10():426. PubMed ID: 31316471
[No Abstract] [Full Text] [Related]
58. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
[TBL] [Abstract][Full Text] [Related]
59. Involvement of the receptor for advanced glycation-end products (RAGE) in beta-amyloid-induced toxic effects in rat cerebromicrovascular endothelial cells cultured in vitro.
Baiguera S; Fioravanzo L; Grandi C; Di Liddo R; Parnigotto PP; Folin M
Int J Mol Med; 2009 Jul; 24(1):9-15. PubMed ID: 19513528
[TBL] [Abstract][Full Text] [Related]
60. Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.
Cheng Y; Zhong J; Xiang Y; Zeng F; Cai D; Zhao L
Clin Interv Aging; 2014; 9():1981-6. PubMed ID: 25429209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
